Global Spine Biologics Market 2016-2020
SKU ID :TNV-10290112 | Published Date: 08-Jun-2016 | No. of pages: 79Description
About the Spine Biologics Market
The global spine biologics market has seen an ideal shift in the past few years. The market is witnessing growth because of the developments and adoption of spine biologic by end-users.
The market is driven by factors such as the increase in older adult population and growing incidence of spinal disorders such as herniated discs, degenerative disc disease, spondylolisthesis, prolapsed intervertebral disc, and spinal stenosis. A shift in preference for MI surgeries over open surgeries has led to the development of technologically advanced spinal implants, which leads to an increased demand for spine biologics. An increasing number of lumbar fusion procedures being performed, and rising popularity among the younger and active patient population to retain some movement and flexibility, are some of the trends currently being witnessed in the market.
Technavio’s analysts forecast the global spine biologics market to grow at a CAGR of 2.07% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global spine biologics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of the following:
• Allograft
• Stem cells
• Bone morphogenetic proteins (BMPs)
• Demineralized bone matrix (DBM)
• Synthetic bone grafts
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Spine Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• SeaSpine
Other prominent vendors
• Alphatec Spine
• AMEDICA
• Anika Therapeutics
• Arthrex
• Baxter
• Berkeley Advanced Biomaterial
• Biomimetic Therapeutics
• Globus Medical
• Integra Life Sciences
• ISTO Technologies
• K2M
• LDR
• Orthofix International
• RTI Surgical
• Xtant Medical
Market driver
• Growing popularity of MI spinal and robot-assisted surgeries
• For a full, detailed list, view our report
Market challenge
• Complications associated with spine implants in spine surgeries
• For a full, detailed list, view our report
Market trend
• Emerging MI sacroiliac joint fusion technique
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The global spine biologics market has seen an ideal shift in the past few years. The market is witnessing growth because of the developments and adoption of spine biologic by end-users.
The market is driven by factors such as the increase in older adult population and growing incidence of spinal disorders such as herniated discs, degenerative disc disease, spondylolisthesis, prolapsed intervertebral disc, and spinal stenosis. A shift in preference for MI surgeries over open surgeries has led to the development of technologically advanced spinal implants, which leads to an increased demand for spine biologics. An increasing number of lumbar fusion procedures being performed, and rising popularity among the younger and active patient population to retain some movement and flexibility, are some of the trends currently being witnessed in the market.
Technavio’s analysts forecast the global spine biologics market to grow at a CAGR of 2.07% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global spine biologics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of the following:
• Allograft
• Stem cells
• Bone morphogenetic proteins (BMPs)
• Demineralized bone matrix (DBM)
• Synthetic bone grafts
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Spine Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• SeaSpine
Other prominent vendors
• Alphatec Spine
• AMEDICA
• Anika Therapeutics
• Arthrex
• Baxter
• Berkeley Advanced Biomaterial
• Biomimetic Therapeutics
• Globus Medical
• Integra Life Sciences
• ISTO Technologies
• K2M
• LDR
• Orthofix International
• RTI Surgical
• Xtant Medical
Market driver
• Growing popularity of MI spinal and robot-assisted surgeries
• For a full, detailed list, view our report
Market challenge
• Complications associated with spine implants in spine surgeries
• For a full, detailed list, view our report
Market trend
• Emerging MI sacroiliac joint fusion technique
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
TOC
Tables & Figures
Companies
- PRICE
-
$2500$4000Buy Now